Literature DB >> 21029690

[Association between HPV infection and HLA-DQB1 alleles polymorphism in the cervical carcinogenesis in Uyghur women in southern Xinjiang].

Abliz Guzalinuer1, Abudu Mihrinsa, Su-qin Zhang, Hua Li, Nayimu Gulishare, Guo-qing Zhang.   

Abstract

OBJECTIVE: To investigate the association between HPV infection and HLA-DQB1 alleles polymorphism in the cervical carcinogenesis in Uyghur women in southern Xinjiang.
METHODS: Twenty-one subtypes of HPV and the 5 alleles of HLA-DQB1 were detected from cervical tissues of 190 cervical cancer cases and 190 normal subjects by flow-through hybridization and gene chip (HybriMax) assay and polymerase chain reaction sequence-specific oligonucleotide technique (PCR-SSO).
RESULTS: (1) The positive rate of HPV in cervical cancer and control groups were 70.0% and 8.9%, respectively. HPV16 was the most common type in HPV positive cervical cancer patients with a rate of 64.7%, followed by HPV18 (2.6%), HPV68 (2.1%), HPV45 (1.6%), HPV58 (1.6%), HPV39 (1.6%), HPV31 (1.1%), HPV56 (1.1%), HPV59 (0.5%), HPV53 (0.5%) and HPV6 (0.5%), respectively. The positive rates of HPV and HPV16 in the cervical cancer group were significantly higher than that in the control group. (2) The frequency of HLA-DQB1*03 was significantly lower than that in the control group (OR = 0.683, 95%CI = 0.505 - 0.923). The frequency of other HLA alleles had no significant differences between the cervical cancer group and the control group. (3) In the cervical cancer group, the frequency of HLA-DQB1*06 in both HPV positive and HPV16 positive cases were significantly higher than that in both the HPV and HPV16 negative cases.
CONCLUSION: HPV16 is the most common type in both the cervical cancer and control groups. It appears that HLA-DQB1*03 may be a protective gene in the cervical carcinogenesis in southern Xinjiang Uyghur women, and the HLA-DQB1*06 is a susceptibility gene to HPV/HPV16 infection in Uyghur women. The study of HLA alleles in the cervical carcinogenesis in Uyghur women may play an important role in the intervention research of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029690

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  5 in total

1.  The correlation between HLA-DRB1 and HLA-DQB1 gene polymorphisms and cytokines in HPV16 infected women with advanced cervical cancer.

Authors:  Yan Liu; Jian Zhang; Zhong-Ming Jia; Ji-Chang Li; Chun-Hua Dong; Yong-Mei Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study.

Authors:  Sofía Bernal-Silva; Julio Granados; Clara Gorodezky; Carmen Aláez; Hilario Flores-Aguilar; Ricardo M Cerda-Flores; Geraldina Guerrero-González; Lezmes D Valdez-Chapa; José Morales-Casas; Juan Francisco González-Guerrero; Hugo A Barrera-Saldaña
Journal:  Infect Agent Cancer       Date:  2013-08-30       Impact factor: 2.965

3.  Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.

Authors:  Priyanka Gokhale; Shilpa Kerkar; Hemant Tongaonkar; Hemangi Chaudhari; Himangi Warke; Vinita Salvi; Jayanti Mania-Pramanik
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

4.  Risk factors associated with human papillomavirus infection status in a Korean cohort.

Authors:  H Lee; D-H Lee; Y-M Song; K Lee; J Sung; G Ko
Journal:  Epidemiol Infect       Date:  2013-10-21       Impact factor: 4.434

5.  The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population.

Authors:  Amanda Vansan Marangon; Gláucia Andreia Soares Guelsin; Jeane Eliete Laguila Visentainer; Sueli Donizete Borelli; Maria Angélica Ehara Watanabe; Márcia Edilaine Lopes Consolaro; Katiany Rizzieri Caleffi-Ferracioli; Cristiane Conceição Chagas Rudnick; Ana Maria Sell
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.